Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients

NCT03781479 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscular Atrophy, Spinal

Interventions

DRUG: Amifampridine Phosphate
DRUG: Placebo Oral Tablet

Sponsor

Catalyst Pharmaceuticals, Inc.